Gregory Mayhew

基本信息

浏览量：13

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 58 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 1040: Development of a Novel RNA-based Microsatellite Stable Predictive Response Signature (MSS-PRS) to Identify MSS Colorectal Cancer (CRC) Patients with a Microsatellite Instability-High (MSI-H) Molecular Phenotype

Kirk Pappan,Gregory Mayhew, Jonathan Shepherd,Yuelong Guo,Kirk Beebe,Joel Eisner,Michael Milburn

Cancer researchno. 6_Supplement (2024): 1040-1040

引用0浏览0引用

Figure S1 from Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer

Joel R. Eisner, Florus C. de Jong,Yoichiro Shibata,Gregory M. Mayhew,James M. Davison,Jenna Carcione, Kirk L. Pappan,Shibu Thomas,Spyros Triantos,Ademi Santiago-Walker,Mahadi Baig, Michael V. Milburn, Kirk D. Beebe,Tahlita C.M. Zuiverloon

crossref（2024）

引用0浏览0引用

Development of a Novel RNA-based Fibroblast Growth Factor Receptor Response Signature (FGFR-PRS) for Use in Patients with Urothelial Cancer (UC)

Kirk L. Pappan,Gregory Mayhew,James M. Davison,Yoichiro Shibata,Joel Robert Eisner,Kirk Beebe,Michael Vance Milburn

Journal of Clinical Oncologyno. 4_suppl (2024): 548-548

引用0浏览0引用

Clinical Validation of a Mesenchymal Gene Expression Signature for Prognosis and Treatment Decision Making in Early-Stage Oral Cavity Squamous Cell Carcinoma

David N. Hayes,Gregory Mayhew,Joshua M. Uronis,Jose Zevallos

Journal of Clinical Oncologyno. 16_suppl (2024): 6091-6091

引用0浏览0引用

Characterization of FGFR Alterations and Activation in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer

Joel R. Eisner,Florus C. de Jong,Yoichiro Shibata,Gregory M. Mayhew,James M. Davison,Jenna Carcione, Kirk L. Pappan,Shibu Thomas,Spyros Triantos,Ademi Santiago-Walker,Mahadi Baig,Michael V. Milburn,Kirk D. Beebe,Tahlita C. M. Zuiverloon

CLINICAL CANCER RESEARCHno. 23 (2024): 5374-5384

引用0浏览0WOS引用

Supplementary Data Tables 1 from Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer

crossref（2024）

引用0浏览0引用

Abstract 2542: Real-world Validation of the PurIST Classifier Demonstrates Enhanced Therapy Selection for Pancreatic Ductal Adenocarcinoma (PDAC) Patients

Stephane Wenric,James M. Davison,John Guittar,Gregory M. Mayhew,Kirk Beebe, Alia Zander,Seung Won Hyun, Kyle Beauchamp,Michael V. Milburn,Vincent Chung,Tanios S. Bekaii-Saab,Charles M. Perou

Cancer researchno. 6_Supplement (2024): 2542-2542

引用0浏览0引用

Development of a Novel RNA-based Immune Checkpoint Inhibitor Response Signature (ICI-PRS) That Avoids Standard-of-care (SOC) Prognostic Signal for Use in Patients with Urothelial Cancer (UC)

Jonathan Shepherd,Gregory Mayhew,John Guo,Kirk Beebe,Joel Robert Eisner,Michael Vance Milburn

Journal of Clinical Oncologyno. 4_suppl (2024): 549-549

引用0浏览0引用

Supplementary Figure S2 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: the Piedmont Study

Joel R. Eisner,Gregory M. Mayhew,James M. Davison,Kirk D. Beebe,Yoichiro Shibata,Yuelong Guo,Carol Farhangfar,Farhang Farhangfar,Joshua M. Uronis,Jeffrey M. Conroy,Michael V. Milburn,David Neil Hayes,Kathryn F. Mileham

crossref（2023）

引用0浏览0引用

Real-world data validation of the PurIST pancreatic ductal adenocarcinoma gene expression classifier and its prognostic implications

Stephane Wenric,James M. Davison,John Guittar,Gregory M. Mayhew,Kirk D. Beebe,Yun E. Wang,Amrita A. Iyer, Hyunseok P. Kang,Michael V. Milburn,Vincent Chung,Tanios Bekaii-Saab,Charles M. Perou

medRxiv (Cold Spring Harbor Laboratory) (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

学生

论文共 58 篇作者统计合作学者相似作者